Business Description
GeneTether Therapeutics Inc
NAICS : 325412
SIC : 3741
ISIN : CA37187D1087
Description
GeneTether Therapeutics Inc is a genetic medicines company focused on the development of high-efficiency precision gene editing for human therapeutics applications. It is engaged in creating gene-editing therapies based on the proprietary GeneTether platform. Further, it is focused on building a discovery pipeline for the treatment of rare, monogenic diseases of the kidney and the skin. Their platform is designed to increase the efficiency of genome editing technologies, including CRISPR-Cas, TALENs, and ZFNs.
Financial Strength
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | No Debt | |||||
Equity-to-Asset | 0.96 | |||||
Interest Coverage | No Debt | |||||
Piotroski F-Score | 5/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | -122.4 | |||||
3-Year EPS without NRI Growth Rate | -91.3 | |||||
3-Year FCF Growth Rate | -86.6 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
12-1 Month Momentum % | -63.24 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 22.93 | |||||
Quick Ratio | 22.93 | |||||
Cash Ratio | 22.92 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | 5.6 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROE % | -43.87 | |||||
ROA % | -42.32 | |||||
ROIC % | -1189.78 | |||||
ROCE % | -48.45 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PB Ratio | 0.48 | |||||
Price-to-Tangible-Book | 0.5 | |||||
EV-to-EBIT | 1.01 | |||||
EV-to-EBITDA | 1.01 | |||||
EV-to-FCF | 1.58 | |||||
Price-to-Net-Current-Asset-Value | 0.5 | |||||
Price-to-Net-Cash | 0.5 | |||||
Earnings Yield (Greenblatt) % | 99.01 | |||||
FCF Yield % | -76.77 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:GNTTF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
GeneTether Therapeutics Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | |||
EPS (TTM) ($) | -0.008 | ||
Beta | 0 | ||
Volatility % | 63.24 | ||
14-Day RSI | 0 | ||
14-Day ATR ($) | 0.000007 | ||
20-Day SMA ($) | 0.01 | ||
12-1 Month Momentum % | -63.24 | ||
52-Week Range ($) | 0.01 - 0.0272 | ||
Shares Outstanding (Mil) | 38.74 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 5 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
GeneTether Therapeutics Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
GeneTether Therapeutics Inc Stock Events
Event | Date | Price($) | ||
---|---|---|---|---|
No Event Data |
GeneTether Therapeutics Inc Frequently Asked Questions
What is GeneTether Therapeutics Inc(GNTTF)'s stock price today?
The current price of GNTTF is $0.01. The 52 week high of GNTTF is $0.03 and 52 week low is $0.01.
When is next earnings date of GeneTether Therapeutics Inc(GNTTF)?
The next earnings date of GeneTether Therapeutics Inc(GNTTF) is .
Does GeneTether Therapeutics Inc(GNTTF) pay dividends? If so, how much?
GeneTether Therapeutics Inc(GNTTF) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |